Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hartleb

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Hepato-Gastroenterology|December 1, 1984
Evidence of improvement in deficient gastroenterological diagnosis--a regional experience reportK Gibiński, M Hartleb, D Koturbasz
The American Journal of Gastroenterology|May 11, 1999
Acute cholestatic hepatitis associated with pravastatinM Hartleb, G Rymarczyk, K Januszewski
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1983
The bioavailability of three dipyridamole productsA Markiewicz, M Hartleb, H Boldys
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 1, 1992
[Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis]M Mandera, E Nowakowska-Duława, M Hartleb
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|November 19, 1984
[Zieve's syndrome as a particular form of alcoholic fatty liver]M Hartleb, B Zahorska-Markiewicz, H Bołdys
The American Journal of Gastroenterology|June 1, 1987
Wilson's disease presenting in sisters as fulminant hepatitis with hemolytic episodesM Hartleb, B Zahorska-Markiewicz, A Ciesielski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|June 15, 1989
[Giant hepatic hemangioma--diagnostic value of radioisotope investigations]M Hartleb, T Kloc, J Checińska-Jefimiuk
Polskie Archiwum Medycyny Wewnetrznej|December 1, 1990
[Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases]M Hartleb, A Nowak, A Becker, et al.
Endoscopy|November 1, 1996
Short-term effects of variceal sclerotherapy on portal hypertensive gastropathyH Boldys, T Romanczyk, M Hartleb, et al.
Journal of Hepatology|February 1, 1995
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosisM Hartleb, R Moreau, C Gaudin, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Hepato-Gastroenterology|December 1, 1984
Evidence of improvement in deficient gastroenterological diagnosis--a regional experience reportK Gibiński, M Hartleb, D Koturbasz
The American Journal of Gastroenterology|May 11, 1999
Acute cholestatic hepatitis associated with pravastatinM Hartleb, G Rymarczyk, K Januszewski
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1983
The bioavailability of three dipyridamole productsA Markiewicz, M Hartleb, H Boldys
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|May 1, 1992
[Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis]M Mandera, E Nowakowska-Duława, M Hartleb
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|November 19, 1984
[Zieve's syndrome as a particular form of alcoholic fatty liver]M Hartleb, B Zahorska-Markiewicz, H Bołdys
The American Journal of Gastroenterology|June 1, 1987
Wilson's disease presenting in sisters as fulminant hepatitis with hemolytic episodesM Hartleb, B Zahorska-Markiewicz, A Ciesielski
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|June 15, 1989
[Giant hepatic hemangioma--diagnostic value of radioisotope investigations]M Hartleb, T Kloc, J Checińska-Jefimiuk
Polskie Archiwum Medycyny Wewnetrznej|December 1, 1990
[Effect of smoking on caffeine elimination by the liver in patients with chronic liver diseases]M Hartleb, A Nowak, A Becker, et al.
Endoscopy|November 1, 1996
Short-term effects of variceal sclerotherapy on portal hypertensive gastropathyH Boldys, T Romanczyk, M Hartleb, et al.
Journal of Hepatology|February 1, 1995
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosisM Hartleb, R Moreau, C Gaudin, et al.
Pageof 10